J C Kaski

Author PubWeight™ 121.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997 2.95
2 Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004 2.71
3 Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) 1998 2.68
4 Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999 2.17
5 Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991 2.16
6 Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. N Engl J Med 1990 1.89
7 Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991 1.87
8 Role of adenosine in pathogenesis of anginal pain. Circulation 1990 1.60
9 Rarefaction of skin capillaries in patients with anginal chest pain and normal coronary arteriograms. Eur Heart J 2001 1.58
10 Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 1990 1.55
11 Angiographic stenosis progression and coronary events in patients with 'stabilized' unstable angina. Circulation 1995 1.54
12 Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J 2001 1.54
13 Effect of theophylline on exercise-induced myocardial ischaemia. Lancet 1989 1.52
14 Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris. J Am Coll Cardiol 1998 1.48
15 C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J 2000 1.46
16 Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J 1996 1.46
17 Reactivity of proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina pectoris. Am J Cardiol 1991 1.45
18 The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina. Am J Cardiol 1982 1.44
19 Effect of magnesium sulphate in patients with unstable angina. A double blind, randomized, placebo-controlled study. Eur Heart J 1997 1.41
20 Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome. Int J Cardiol 2010 1.41
21 Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006 1.40
22 Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study. Eur Heart J 1996 1.39
23 Variability of coronary blood flow reserve assessed by Doppler catheter after successful thrombolysis in patients with acute myocardial infarction. Am Heart J 1993 1.39
24 Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001 1.31
25 Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol 1991 1.23
26 Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. Circulation 1981 1.22
27 Clinical factors and angiographic features associated with premature coronary artery disease. Chest 1995 1.22
28 Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 1986 1.21
29 Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol 2000 1.17
30 The role of neopterin in atherogenesis and cardiovascular risk assessment. Curr Med Chem 2009 1.15
31 Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X. Circulation 1994 1.11
32 Chlamydia pneumoniae infection and coronary artery disease. J Am Coll Cardiol 1999 1.08
33 CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart 2004 1.08
34 Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris. Am J Cardiol 1985 1.07
35 Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation 1986 1.03
36 Assessment of quality of life in patients with chest pain and normal coronary arteriogram (syndrome X) using a specific questionnaire. Clin Cardiol 1999 1.02
37 Endothelial dysfunction, subangiographic atheroma, and unstable symptoms in patients with chest pain and normal coronary arteriograms. Clin Cardiol 2000 0.99
38 Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X). Clin Cardiol 2001 0.98
39 Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 2004 0.96
40 Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease. Am J Cardiol 1993 0.95
41 Pain threshold and tolerance in women with syndrome X and women with stable angina pectoris. Am J Cardiol 1987 0.95
42 Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol 1994 0.94
43 Inflammatory systemic biomarkers in setting acute coronary syndromes--effects of the diurnal variation. Curr Drug Targets 2009 0.93
44 High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am J Cardiol 2001 0.93
45 Heart rate variability depression in patients with unstable angina. Am Heart J 1995 0.92
46 Induction of coronary artery spasm by a direct local action of ergonovine. Circulation 1987 0.91
47 Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome X. Am J Cardiol 2000 0.90
48 Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia. Am J Cardiol 1985 0.88
49 Effects of beta 2-adrenoceptor stimulation on exercise-induced myocardial ischemia. Am J Cardiol 1991 0.88
50 Transient myocardial ischemia during daily life in patients with syndrome X. Am J Cardiol 1986 0.88
51 Coronary vasomotor effects of serotonin in patients with angina. Relation to coronary stenosis morphology. Circulation 1993 0.88
52 Mixed angina pectoris. Am J Cardiol 1985 0.88
53 Serum neopterin in acute coronary syndromes. Lancet 1997 0.87
54 Transient autonomic dysfunction precedes ST-segment depression in patients with syndrome X. Am J Cardiol 1996 0.87
55 Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty. Br Heart J 1995 0.86
56 Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy. Heart 1996 0.85
57 Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms. Eur Heart J 1998 0.85
58 Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol 2000 0.85
59 Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools. J Intern Med 2007 0.85
60 Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 1995 0.85
61 Emotional triggering and low socio-economic status as determinants of depression following acute coronary syndrome. Psychol Med 2011 0.84
62 Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms. J Am Coll Cardiol 1999 0.83
63 Creatine kinase MB isoforms: sensitive markers of ischemic myocardial damage. Clin Chem 1994 0.83
64 Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: pathophysiological implications in coronary disease. Endothelium 1998 0.83
65 Increased QT dispersion in patients with Prinzmetal's variant angina and cardiac arrest. Cardiovasc Res 2001 0.83
66 Histological patterns of atherosclerotic plaques in unstable angina patients vary according to clinical presentation. Heart 1998 0.82
67 Complex stenosis morphology predicts late reocclusion during follow-up after myocardial infarction in patients with patent infarct-related coronary arteries. Am Heart J 1998 0.82
68 Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma. Br J Cancer 1998 0.82
69 Increased serum neopterin: a marker of coronary artery disease activity in women. Heart 2000 0.82
70 Regional variations in ETA/ETB binding sites in human coronary vasculature. J Cardiovasc Pharmacol 1995 0.81
71 Enhanced vasomotor responses of complex coronary stenoses to acetylcholine in stable angina pectoris. Am J Cardiol 1995 0.81
72 Abnormal uptake and washout of thallium-201 in patients with syndrome X and normal-appearing scans. Am J Cardiol 1995 0.81
73 Atherosclerotic plaque regression - the role of statin therapy. Drugs Today (Barc) 2010 0.81
74 Negative stress echocardiographic responses in normotensive and hypertensive patients with angina pectoris, positive exercise stress testing, and normal coronary arteriograms. Heart 2000 0.81
75 Differential progression of complex and smooth stenoses within the same coronary tree in men with stable coronary artery disease. J Am Coll Cardiol 1995 0.80
76 Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X). Heart 1997 0.80
77 Effects of aminophylline on cardiac function and regional myocardial perfusion: implications regarding its antiischemic action. Am Heart J 1994 0.80
78 Preangioplasty complicated coronary stenosis morphology as a predictor of restenosis. Am Heart J 1992 0.80
79 Relation between stimulation site of cardiac afferent nerves by adenosine and distribution of cardiac pain: results of a study in patients with stable angina. J Am Coll Cardiol 1992 0.80
80 Peroxisome proliferator activated receptor gamma: a potential therapeutic target in the management of ischaemic heart disease. Heart 2001 0.80
81 Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome. Eur Heart J 1998 0.80
82 Antioxidant treatment for heart failure: friend or foe? QJM 2008 0.80
83 Heart rate response during exercise testing and ambulatory ECG monitoring in patients with syndrome X. Am Heart J 1991 0.80
84 The natural history of unheralded complex coronary plaques. J Am Coll Cardiol 1996 0.79
85 The role of T and B cells in atherosclerosis: potential clinical implications. Curr Pharm Des 2011 0.79
86 Angiographic progression in patients with angina pectoris and normal or near normal coronary angiograms who are restudied due to unstable symptoms. Eur Heart J 1998 0.79
87 Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction. Heart 2006 0.79
88 Variability of results during repeat exercise stress testing in patients with stable angina pectoris: role of dynamic coronary flow reserve. Am Heart J 1986 0.78
89 Comparative effects of theophylline and isosorbide dinitrate on exercise capacity in stable angina pectoris, and their mechanisms of action. Am J Cardiol 1989 0.78
90 Mechanisms and significance of cardiac ischemic pain. Prog Cardiovasc Dis 1992 0.78
91 Electrocardiographic diagnosis of transient myocardial ischemia. Sensitivity, specificity, and practical significance. Ann N Y Acad Sci 1990 0.78
92 Atheromatous plaque location and arterial remodelling. Eur Heart J 2003 0.78
93 Antianginal and anti-ischaemic efficacy of tedisamil, a potassium channel blocker. Heart 2000 0.78
94 Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X. Am J Cardiol 1989 0.78
95 Effect of alpha1-adrenoceptor blockade on coronary vasodilator reserve in cardiac syndrome X. J Cardiovasc Pharmacol 1999 0.78
96 Provocation of coronary spasm by dopamine in patients with active variant angina pectoris. Circulation 1986 0.78
97 Usefulness of Holter monitoring to improve the sensitivity of exercise testing in determining the degree of myocardial revascularization after coronary artery bypass grafting for stable angina pectoris. Am J Cardiol 1987 0.78
98 Myocardial ischemia during ergonovine testing: different susceptibility to coronary vasoconstriction in patients with exertional and variant angina. Circulation 1984 0.77
99 Aggressive pattern of angina after successful coronary angioplasty: the role of clinical and angiographic factors. Eur Heart J 1995 0.77
100 Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X. Am J Cardiol 1996 0.77
101 Differential progression of complex culprit stenoses in patients with stable and unstable angina pectoris. J Am Coll Cardiol 1996 0.77
102 Plasma immunoreactive endothelin concentration correlates with severity of coronary artery disease in patients with stable angina pectoris and normal ventricular function. J Am Coll Cardiol 1996 0.77
103 Inflammatory biomarkers of coronary atheromatous plaque vulnerability. Panminerva Med 2005 0.77
104 The relationship between change and initial value: the continuing problem of regression to the mean. Eur Heart J 1995 0.77
105 Key references on coronary artery spasm. Circulation 1994 0.77
106 Detection of Chlamydia pneumoniae in atherosclerotic tissue: a comparative study of PCR and immunocytochemistry. Br J Biomed Sci 2005 0.77
107 Chronic infections and coronary heart disease. Int J Clin Pract 1999 0.77
108 Recovery-phase patterns of ST segment depression in the heart rate domain cannot distinguish between anginal patients with coronary artery disease and patients with syndrome X. Am Heart J 1991 0.76
109 Improved coronary supply: prevailing mechanism of action of nitrates in chronic stable angina. Am Heart J 1985 0.76
110 Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease. Am Heart J 1984 0.76
111 Cardiac imaging in syndrome X: the problem of "reverse redistribution'. Eur Heart J 1996 0.76
112 Release of platelet activation markers during coronary angioplasty. Coron Artery Dis 2000 0.76
113 Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris. Am Heart J 1998 0.76
114 Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques. Heart 2005 0.76
115 Serum endothelin levels and pain perception in patients with cardiac syndrome X and in healthy controls. Am J Cardiol 1997 0.75
116 C-reactive protein as a clinical marker of risk. Circulation 2000 0.75
117 'Comments on circulating transforming growth factor beta 1 and coronary artery disease'. Cardiovasc Res 1998 0.75
118 Local cytokine production and acute coronary events. Int J Cardiol 2000 0.75
119 Refractory variant angina relieved by guanethidine and clonidine. Am J Cardiol 1988 0.75
120 Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1998 0.75
121 Treatment of stable angina pectoris: is there a role for dipyridamole? Eur Heart J 2001 0.75
122 Chronic infection and atherogenesis. Eur Heart J 1998 0.75
123 [3H]bosentan binding to human coronary artery: functional correlates. J Cardiovasc Pharmacol 1995 0.75
124 Polymorphism in apolipoprotein(a) kringle IV 37(Met/Thr): frequency in a London population and its association with coronary artery disease. Clin Cardiol 1997 0.75
125 A comparative study of eccentric and concentric coronary stenosis vasomotion in patients with Prinzmental's variant angina and patients with stable angina pectoris. Clin Cardiol 1998 0.75
126 Factor V Leiden polymorphism (FV Q506) in patients with ischaemic heart disease, and in different populations groups. J Hum Hypertens 1996 0.75
127 Duration of ST segment depression after exercise-induced myocardial ischemia is influenced by body position during recovery but not by type of exercise. Am Heart J 1991 0.75
128 Statin treatment for all individuals with cholesterol concentrations above "target"?: "Primum non nocere"--Hippocratic oath. Cardiovasc Drugs Ther 2012 0.75
129 Angiotensin-converting enzyme insertion/deletion polymorphism in angina pectoris with normal coronary arteriograms. Am J Cardiol 1996 0.75
130 [Starting light alcohol drinking for prevention of coronary disease: too little too late?]. Herz 2002 0.75
131 Effects of theophylline, atenolol and their combination on myocardial ischemia in stable angina pectoris. Am J Cardiol 1990 0.75
132 Similar time course of ST depression during and after exercise in patients with coronary artery disease and syndrome X. Am Heart J 1990 0.75
133 Prediction of infarction-related artery occlusion and multivessel disease in postinfarction angina. Int J Cardiol 2006 0.75
134 [Coronary artery spasm: physiopathology and clinical presentation]. Rev Port Cardiol 1998 0.75
135 Assessment of high on-treatment platelet reactivity in patients with ischemic heart disease: concordance between the Multiplate and VerifyNow assays. J Thromb Haemost 2013 0.75
136 A combination of electrocardiographic methods represents a further step toward the noninvasive identification of patients with syndrome X. Am Heart J 1992 0.75
137 [Approach to coronary artery spasm]. Rev Port Cardiol 1998 0.75
138 Methylenetetrahydrofolate reductase polymorphism (C-677T) and coronary artery disease. Clin Sci (Lond) 1998 0.75
139 Effects of diltiazem alone or with isosorbide dinitrate or with atenolol both acutely and chronically for stable angina pectoris. Am J Cardiol 1989 0.75
140 Ischemic threshold varies in response to different types of exercise in patients with chronic stable angina. Am Heart J 1989 0.75
141 [Secondary prevention of coronary artery disease: interaction between the hospital and outpatient clinic in or der to form successful, low-cost strategies]. Rev Port Cardiol 2000 0.75
142 Heart rate-independent prolongation of QTc interval in women with syndrome X. Clin Cardiol 1997 0.75
143 Is amiodarone an ideal antiarrhythmic drug? Pacing Clin Electrophysiol 1984 0.75
144 Endothelin-like immunoreactivity in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol 1995 0.75
145 Adenosine-induced chest pain in patients with silent and painful myocardial ischaemia: another clue to the importance of generalized defective perception of painful stimuli as a cause of silent ischaemia. Eur Heart J 1988 0.75
146 [Acute coronary infarcts: close connection between inflammation and thrombosis]. Herz 2002 0.75
147 Endothelial dysfunction in the absence of coronary atheroma causing Prinzmetal's angina. Heart 1997 0.75
148 [The polymorphism of the angiotensin I-converting enzyme gene and its association with ischemic cardiopathy]. Rev Esp Cardiol 1996 0.75
149 [Progress in the knowledge on endothelial dysfunction and its application in clinical practice]. Rev Esp Cardiol 2001 0.75
150 [The diagnosis of myocardial damage during coronary angioplasty by the analysis of the isoforms of the enzyme creatine kinase MB]. Rev Esp Cardiol 1995 0.75
151 Long-term variability of angina pectoris and electrocardiographic signs of ischemia in syndrome X. Am J Cardiol 1989 0.75
152 [Inflammation, infection and coronary artery disease: myths and realities. Special XXXV Conference of the National Congress of the Spanish Society of Cardiology]. Rev Esp Cardiol 2000 0.75
153 Patterns of coronary artery stenosis vasomotion: observed versus "predicted" stenosis reactivity in patients with chronic stable angina. Coron Artery Dis 1993 0.75
154 Efficacy of amiodarone in patients with Chagas' disease and life-threatening arrhythmias. Br J Clin Pract Suppl 1986 0.75
155 Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation. J Heart Lung Transplant 1996 0.75